Inflammation and Immunity in Cardiovascular Diseases
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 56
Special Issue Editor
Interests: inflammation; ischemia–reperfusion injury; cardiovascular physiology; hypertension; cardiovascular disease
Special Issue Information
Dear Colleagues,
Chronic inflammation and dysregulated immune responses are central contributors to the development and progression of cardiovascular diseases (CVDs), including atherosclerosis, heart failure, and ischemic injury. As our understanding of the immune–cardiovascular interface deepens, precision strategies targeting inflammatory pathways have emerged as promising tools for both risk stratification and therapeutic intervention. This Special Issue invites original research and review articles that explore the roles of innate and adaptive immunity, inflammatory signaling cascades, and immune–metabolic crosstalk in cardiovascular pathology. We welcome studies examining the impact of comorbidities such as obesity, diabetes, and environmental exposures on immune activation in the cardiovascular system. Submissions highlighting novel biomarkers, therapeutic targets, or personalized treatment strategies in the context of cardiovascular inflammation are especially encouraged. Our aim is to bring together interdisciplinary insights that advance the precision medicine approach to cardiovascular care.
Dr. Nathan A. Holland
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular inflammation
- immune modulation
- ischemia–reperfusion injury
- personalized medicine
- inflammatory biomarkers
- cardiometabolic disease
- environmental exposures
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
